Ticagrelor Therapy for RefrACTORy Migraine Study
NCT02518464
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Headache
Migraine Headache
Interventions
DRUG:
Ticagrelor 90 mg twice per day
Sponsor
Columbia University
Collaborators
[object Object]